Current methodologies for the isolation and study of CSC are based on the expression of surface markers specifically identified in different cancer types; CD133, in particular, has been widely utilized as a biomarker for the isolation of cells that exhibit a stem-like phenotype in a variety of cancer tissues [8]. The gene discussed is PROM1; the disease is cancer.